Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Diertine
2. Dihydroergocristine
3. Dihydroergocristine Monomesylate
4. Enirant
5. Ergodavur
6. Mesylate, Dihydroergocristine
7. Monomesylate, Dihydroergocristine
1. 24730-10-7
2. Dihydroergocristinmesilat
3. Dihydroergocristine Mesilate
4. 9,10-dihydroergocristine Methanesulfonate
5. Dihydroergocristine Methanesulfonate
6. Mls000069354
7. Ds7cl18uam
8. Smr000058240
9. Chebi:31490
10. (6ar,9r,10ar)-n-[(1s,2s,4r,7s)-7-benzyl-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic Acid
11. 5'alpha-benzyl-9,10alpha-dihydro-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione Monomethanesulphonate
12. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'alpha,10alpha)-, Methanesulfonate (1:1)
13. Dihydroergocristine (mesylate)
14. Unii-ds7cl18uam
15. Sr-01000075381
16. Dihydroergocristinmesilat [german]
17. Diertine (tn)
18. Prestwick_745
19. Einecs 246-434-6
20. Dihydroergocristine Methanesulfonate Salt
21. Ergocristine, Dihydro-, Methanesulfonate
22. Oxamide Methanesulfonate
23. Opera_id_1422
24. Mls001076298
25. Mls001333686
26. Mls002222256
27. Schembl178144
28. Dihydroergocristine Monomesylate
29. Cid_444034
30. Chembl1255837
31. Bdbm30706
32. Dtxsid20872322
33. Ergocristine, 9,10-dihydro-, Monomethanesulfonate (salt)
34. 9,10-dihydroergocristine Mesilate
35. 9,10-dihydroergocristine Mesylate
36. C35h41n5o5.ch3so3h
37. Hms1569b06
38. Hms2096b06
39. Hms2233k22
40. Hms3411o07
41. Hms3675o07
42. Dihydroergocristine Mesilate (ban)
43. Hy-n2319
44. Mfcd00153792
45. Akos024458318
46. Ccg-208194
47. Ncgc00025380-03
48. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'.alpha.,10.alpha.)-, Monomethanesulfonate (salt)
49. Ergotamane-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'-alpha,10-alpha)-, Monomethanesulfonate (salt)
50. Dihydroergocristine Mesilate [mart.]
51. Dihydroergocristine Mesylate [vandf]
52. Cs-0020631
53. D-155
54. Dihydroergocristine Mesilate [who-dd]
55. Eu-0100409
56. Mls000069354-02
57. D07833
58. Dihydroergocristine Methanesulfonate [mi]
59. 9,10-dihydroergocristine Methanesulphonate
60. Dihydroergocristine Mesilate [ep Monograph]
61. Sr-01000000009
62. J-015650
63. Sr-01000000009-2
64. Sr-01000075381-1
65. Q27114325
66. Dihydroergocristine Mesilate, European Pharmacopoeia (ep) Reference Standard
67. (10alphah)-5'alpha-benzyl-12'-hydroxy-3',6',18-trioxo-2'-(propan-2-yl)-9,10-dihydroergotaman Methanesulfonate
68. (5'?,10?)-9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-ergotaman-3',6',18-trione Mesylate
69. (5'alpha,10alpha)-9,10-dihydro-12'-hydroxy-2'-(1 -methylethyl)-5'-(phenylmethyl)-ergotaman-3',6',18-tr Ione Mesylate
70. (6ar,9r,10ar)-n-((2r,5s,10as,10bs)-5-benzyl-10b-hydroxy-2-isopropyl-3,6-dioxooctahydro-2h-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carb
71. (6ar,9r,10ar)-n-((2r,5s,10as,10bs)-5-benzyl-10b-hydroxy-2-isopropyl-3,6-dioxooctahydro-2h-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide Methanesulfonate
72. (6ar,9r,10ar)-n-[(2r,5s,10as,10bs)-5-benzyl-10b-hydroxy-2-(1-methylethyl)-3,6-dioxo-octahydro-8h-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline
73. 5'.alpha.-benzyl-9,10.alpha.-dihydro-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione Monomethanesulphonate
74. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'.alpha.,10.alpha.)-, Monomethanesulphonate (salt)
75. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'alpha,10alpha)-, Monomethanesulfonate (salt)
Molecular Weight | 707.8 g/mol |
---|---|
Molecular Formula | C36H45N5O8S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 5 |
Exact Mass | 707.29888458 g/mol |
Monoisotopic Mass | 707.29888458 g/mol |
Topological Polar Surface Area | 181 Ų |
Heavy Atom Count | 50 |
Formal Charge | 0 |
Complexity | 1300 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Adrenergic Antagonists
Drugs that bind to but do not activate ADRENERGIC RECEPTORS. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters EPINEPHRINE and NOREPINEPHRINE. (See all compounds classified as Adrenergic Antagonists.)
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Dihydroergocristine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydroergocristine, including repackagers and relabelers. The FDA regulates Dihydroergocristine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydroergocristine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dihydroergocristine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dihydroergocristine supplier is an individual or a company that provides Dihydroergocristine active pharmaceutical ingredient (API) or Dihydroergocristine finished formulations upon request. The Dihydroergocristine suppliers may include Dihydroergocristine API manufacturers, exporters, distributors and traders.
click here to find a list of Dihydroergocristine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dihydroergocristine CEP of the European Pharmacopoeia monograph is often referred to as a Dihydroergocristine Certificate of Suitability (COS). The purpose of a Dihydroergocristine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Dihydroergocristine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Dihydroergocristine to their clients by showing that a Dihydroergocristine CEP has been issued for it. The manufacturer submits a Dihydroergocristine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Dihydroergocristine CEP holder for the record. Additionally, the data presented in the Dihydroergocristine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Dihydroergocristine DMF.
A Dihydroergocristine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Dihydroergocristine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Dihydroergocristine suppliers with CEP (COS) on PharmaCompass.
Dihydroergocristine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dihydroergocristine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dihydroergocristine GMP manufacturer or Dihydroergocristine GMP API supplier for your needs.
A Dihydroergocristine CoA (Certificate of Analysis) is a formal document that attests to Dihydroergocristine's compliance with Dihydroergocristine specifications and serves as a tool for batch-level quality control.
Dihydroergocristine CoA mostly includes findings from lab analyses of a specific batch. For each Dihydroergocristine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dihydroergocristine may be tested according to a variety of international standards, such as European Pharmacopoeia (Dihydroergocristine EP), Dihydroergocristine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dihydroergocristine USP).
LOOKING FOR A SUPPLIER?